Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 USD | +0.46% | -1.79% | 0.00% |
21/05 | Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer | CI |
14/05 | Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 32Cr | |
+50.61% | 5.46TCr | |
-4.74% | 3.99TCr | |
+37.57% | 3.88TCr | |
+15.88% | 2.69TCr | |
-12.56% | 2.62TCr | |
-21.56% | 1.88TCr | |
+25.49% | 1.22TCr | |
+1.95% | 1.22TCr | |
+26.99% | 1.19TCr |
- Stock Market
- Equities
- ANRO Stock
- News Alto Neuroscience, Inc.
- Baird Initiates Alto Neuroscience With Outperform Rating, Price Target is $32